Sunday, September 25, 2011

BioMed Central | Full text | Whole plant cannabis extracts in the treatment of spasticity in multiple sclerosis: a systematic review

BioMed Central | Full text | Whole plant cannabis extracts in the treatment of spasticity in multiple sclerosis: a systematic review: "Background
Cannabis therapy has been considered an effective treatment for spasticity, although clinical reports of symptom reduction in multiple sclerosis (MS) describe mixed outcomes. Recently introduced therapies of combined Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) extracts have potential for symptom relief with the possibility of reducing intoxication and other side effects. Although several past reviews have suggested that cannabinoid therapy provides a therapeutic benefit for symptoms of MS, none have presented a methodical investigation of newer cannabinoid treatments in MS-related spasticity. The purpose of the present review was to systematically evaluate the effectiveness of combined THC and CBD extracts on MS-related spasticity in order to increase understanding of the treatment's potential effectiveness, safety and limitations."

'via Blog this'

No comments:

Post a Comment